Competing/conflicts of interest: Dr Schultz serves as Chief Scientific Officer to Direct Contact LLC.
Treatment of corneal defects with delayed re-epithelization with a medical device/drug delivery system for epidermal growth factor
Article first published online: 4 JUN 2012
© 2012 The Authors. Clinical and Experimental Ophthalmology © 2012 Royal Australian and New Zealand College of Ophthalmologists
Clinical & Experimental Ophthalmology
Volume 40, Issue 7, pages 662–668, September/October 2012
How to Cite
Holland, S., Morck, D. and Schultz, C. (2012), Treatment of corneal defects with delayed re-epithelization with a medical device/drug delivery system for epidermal growth factor. Clinical & Experimental Ophthalmology, 40: 662–668. doi: 10.1111/j.1442-9071.2012.02795.x
Funding sources: Susquehanna Capital Management, North Reading, MA, USA.
- Issue published online: 9 OCT 2012
- Article first published online: 4 JUN 2012
- Accepted manuscript online: 19 MAR 2012 09:42AM EST
- Received 25 October 2011; accepted 8 February 2012.
This article has been cited by:
- 1Combined Topical Application of a Regenerative Agent With a Bandage Contact Lens for the Treatment of Persistent Epithelial Defects, Cornea, 2014, 33, 8, 868, , , , , , , ,
- 2Factor de crecimiento epidérmico, innovación y seguridad, Medicina Clínica, 2014,, ,
- 3Contact Lenses: Promising Devices for Ocular Drug Delivery, Journal of Ocular Pharmacology and Therapeutics, 2013, 29, 2, 189, , ,